Frédéric de Blay

Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia

Olivier Hermine, Xavier Mariette, Pierre‐Louis Tharaux et al. · JAMA Internal Medicine · 2020 · 777 citations · Full text

Medicine, Infectious Diseases, Pharmacotherapy +14

Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trial

William W. Busse, Eugene R. Bleecker, J Mark FitzGerald et al. · The Lancet Respiratory Medicine · 2018 · 311 citations

Pharmacy, Pharmacology, Pharmacotherapy +6

Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial

Pierre‐Louis Tharaux, Gilles Pialoux, Arthur Pavot et al. · The Lancet Respiratory Medicine · 2021 · 296 citations · Full text

Veterinary Medicine, Immunology, Pharmacotherapy +14

Specific inhalation challenge in the diagnosis of occupational asthma: consensus statement

Olivier Vandenplas, Hille Suojalehto, Tor Aasen et al. · European Respiratory Journal · 2014 · 209 citations · Full text

Medicine, Clinical Sciences, Hypersensitivity +14

Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial

Tim Harrison, Pascal Chanez, Francesco Menzella et al. · The Lancet Respiratory Medicine · 2020 · 175 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +15